Medical Advocates

HCV Infection/Disease
  European Seroprevalence/Studies/National Challenges
 
Multinational
Belgium
Bosnia
Bulgaria
Croatia
Czech Republic
Denmark
France
Germany
Italy  
Montenegro              
The Netherlands       
Norway
Poland
Portugal
Romania

 
Serbia
Spain
Sweden
Turkey
United Kingdom


 






 









 

HCV Epidemiology Main Page Main New/Newsworthy  Home Page      

Last Update:  December 20, 2017
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Multinational
 

     Journal Papers, Abstracts, and Commentaries
 
 

Epidemiology of Hepatitis C Virus and Genotype Distribution in Immigrants Crossing to Europe from North and Sub-Saharan Africa.
Daw MA, El-Bouzedi A, Ahmed MO, et al
Travel Med Infect Dis. 2016 Aug 5.
Abstract

A literature review of the distribution of hepatitis C virus genotypes across Europe.
Alberti A, Lacoin L, Morais E, et al
J Med Virol
. 2016 May 1
Abstract

Hepatitis C Virus: A European Perspective.
Dultz G, Zeuzem S.  
Gastroenterol Clin North Am
. 2015 Dec;44(4):807-24.

Abstract

Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in 5 EU countries.
Marcellin P, Grotzinger K, Theodore D, et al
J Gastroenterol Hepatol
. 2014 Aug 4
Abstract

FULL-TEXT ARTICLE
Epidemiology of hepatitis C in Europe.

Negro F.
Dig Liver Dis
. 2014 Dec 15;46S5:S158-S164
Paper

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Cornberg M, Razavi HA, Alberti A, et al
Liver Int. 2011 Jul;31 Suppl 2:30-60.
Abstract

Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European
Prospective Investigation into Cancer and Nutrition (EPIC).
Franceschi S, Lise M, Trepo C, et al
Cancer Epidemiol Biomarkers Prev. 2010 Nov 23
Abstract


Belgium
 

     Journal Papers, Abstracts, and Commentaries
 
  The Disease Burden of Hepatitis C in Belgium : An update of a realistic disease control strategy.
Stärkel P, Vandijck D, Laleman W, et al
Acta Gastroenterol Belg. 2015 Apr-Jun;78(2):228-232.
Abstract

HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the
spread of an uncommon HCV genotype 5a cluster.
Verbeeck J, Kwanten L, D'Heygere F,
 et al
Eur J Clin Microbiol Infect Dis
. 2010 Sep 10.

Abstract


Bosnia
       

          Journal Papers, Abstracts, and Commentaries
 
  Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H, Bajramović A, Obradović Z, Mahmić-Kaknjo M.
Glas (Zenica). 2017 Feb 1;14(1):73-78.

Abstract

Bulgaria
       

          Journal Papers, Abstracts, and Commentaries
 
  Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users.
Ciccozzi M, Zehender G, Cento V, et al

J Med Virol
. 2011 Sep;83(9):1565-70.

Abstract

Croatia
       

          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Epidemiology of hepatitis C in Croatia in the European context.
Vilibic-Cavlek T, Kucinar J, Kaic B,  et al 
World J Gastroenterol
. 2015 Aug 28;21(32):9476-93.
Paper

Czech Republic
       

          Journal Papers, Abstracts, and Commentaries
 
  Prevalence and risk factors of hepatitis C in Roma people in Brno.
Husa P, Ovesná P.
Klin Mikrobiol Infekc Lek. 2011 Dec;17(6):201-207

Abstract

Denmark
 

     Journal Papers, Abstracts, and Commentaries
 
  Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland - using spontaneous resolvers as the benchmark comparator.
Innes H, Hutchinson SJ, Obel N, et al  
Hepatology
. 2016 Jan 16.
Abstract

Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark.
Eriksen MB, Jørgensen LB, Krarup
J Med Virol
. 2010 Nov;82(11):1869-1877.

Abstract


France
 

     Journal Papers, Abstracts, and Commentaries

 
 

Contribution of Alcohol Use Disorders on the Burden of Chronic Hepatitis C in France, 2008-2013: A Nationwide Retrospective Cohort Study
Schwarzinger M, Baillot S, Yazdanpanah PY,  et al
Hepatol. 2017 Apr 7
Abstract

Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
Carrieri MP, Protopopescu C, Younossi Z,  et al
Patient. 2017 Mar 28.

Abstract

Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.
Leon L, Kasereka S, Barin F, et al
Epidemiol Infect. 2016 Dec 22:
Abstract

FULL-TEXT ARTICLE
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014.
Brouard C, Le Strat Y, Larsen C, et al
PLoS One. 2015 May 11;10(5):e0126920.
Paper

Care of hepatitis C virus infection in France: modifications in three consecutive surveys between 1995 and 2010.
Geri G, Maynard M, Rosenthal E, et al
Liver Int. 2014 Oct;34(9):1349-57
Abstract

How did chronic hepatitis C impact costs related to hospital health care in France in 2009?
Rotily M, Vainchtock A, Jouaneton B, et al
Clin Res Hepatol Gastroenterol
. 2012 Dec 26..
Abstract

Management of patients with hepatitis C by French psychologists and psychiatrists:
A practical investigation.
Lang JP, Schoeffler M, Michel L, et al
Gastroenterol Clin Bio
l
. 2009 Nov 24
Abstract

 
Germany
       

          Journal Papers, Abstracts, and Commentaries
 
  Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting. [Germany]
ülicher P, Galli C.
J Med Econ. 2017 Sep 7:1-10
Abstract

Real-world treatment for chronic hepatitis C infection in Germany. Analyses from drug prescription data, 2010 - 2015.
Zimmermann R, Kollan C, Ingiliz P, et al
J Hepatol. 2017 Feb 8.
Abstract

Chronic hepatitis C patients prior to broad access to interferon-free treatments in Germany.
Hüppe D, Buggisch P, Christensen S,  et al
Z Gastroenterol
. 2016 Aug;54(8):740-747.

Abstract

Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment.
Mühlbacher AC, Bridges JF, Bethge S, et al
Eur J Health Econ
. 2016 Feb 4
Abstract

Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure. [Germany]
Foerster F, Wörns MA, Galle PR, Schattenberg JM.
Z Gastroenterol. 2015 Dec;53(12):1414-21.
Abstract

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.
Stahmeyer JT, Krauth C, Bert F,  et al
J Viral Hepat. 2015 Sep 28.
Abstract

Hepatitis C in Germany: An Analysis of statutory sickness funds claims data.
Tomeczkowski J, Cornberg M.
Dtsch Med Wochenschr. 2015 Apr;140(8):e67-e73
Abstract

Cost of treating hepatitis C in Germany: a retrospective multicenter analysis.
Stahmeyer JT, Rossol S, Bert F,  et al
Eur J Gastroenterol Hepatol
. 2014 Aug 20.
Abstract

FULL-TEXT ARTICLE
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients.
Beisel C, Heuer M, Otto B,  et al
AIDS Res Ther. 2014 Jul 1;11:16.
Paper

Noncompliance with guidelines for the treatment of hepatitis C is frequent in daily practice.
Niederau C, Mauss S, Böker K, et al
Eur J Gastroenterol Hepatol.
2013 Jun 6
Abstract

Transmission of Hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.
Doerrbecker J, Behrendt P, Mateu-Gelabert P,  et al
J Infect Dis. 2012 Nov 5
Abstract


Greece
 

    
Journal Papers, Abstracts, and Commentaries
 
  Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence? The case of Greece.
Gountas I, Sypsa V, Papatheodoridis G, et al
J Gastroenterol Hepatol
. 2016 Jul 12
Abstract

Italy
 

     Journal Papers, Abstracts, and Commentaries
 
 
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice.[Ital;y]
Loggi E, Gitto S, Galli S, Minichiello M, et al
J Clin Virol. 2017 Jun 3;93:66-70.
Abstract

Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel.
Viganò M, Perno CF, Craxì A; AdHoc (Advancing Hepatitis C for the Optimization of Cure) Working Party..
Dig Liver Dis. 2017 Apr 12. pii: S1590-8658(17)30807-1
Abstract

Treatment of patients with chronic hepatitis C infection in Lombardia: a report by the Lombardia Hepatitis Network.
Aghemo A, Bruno R, Colombo M,
Eur Rev Med Pharmacol Sci. 2016 Dec;20(1 Suppl):17-19.
Abstract

Hepatitis C virus infection: opportunities for an earlier detection in primary care.
Lapi F, Capogrosso Sansone A, Mantarro S,  et al

Eur J Gastroenterol Hepatol
. 2016 Nov 15.
Abstract

Hepatitis C and immigration: a multicentre study.
Scotto G, Armignacco O, Starnini G,  et al
Infez Med. 2016 Sep 1;24(3):210-216.
Abstract

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives.
Croce D, Bonfanti M, Restelli U.
Clinicoecon Outcomes Res
. 2016 Aug 8;8:377-85.

Abstract

Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment.
Nosotti L, Petrelli A, Genovese D. et al
J Immigr Minor Health
. 2016 Jun 6.
Abstract

Low Vitamin D Levels Are Associated with the Presence of Serum Cryoglobulins in Patients with Chronic HCV Infection.
Gentile I, Scarano F, Celotti A,  et al
In Vivo
. 2015 05-06;29(3):399-404.
Abstract

Distribution Pattern of Hepatitis C Virus Genotypes and Correlation with Viral Load and Risk Factors in Chronic Positive Patients.
Petruzziello A, Coppola N, Loquercio G, et al
Intervirology. 2014 Aug 22;57(6):311-318.
Abstract

Back to the origin of HCV 2c subtype and spreading to the Calabria Region (Southern Italy) over the last two centuries: a phylogenetic study.
Marascio N, Ciccozzi M, Equestre M,  et al
Infect Genet Evol. 2014 Jun 25.
Abstract

Economic Assessment of an Anti-HCV Screening Program in Italy.
Ruggeri M, Coretti S, Gasbarrini A, Cicchetti A.
Value Health. 2013 Sep-Oct;16(6):965-72.
Abstract

Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases.
La Spada E, Soresi M, Giannitrapani L,  et al
Ann Hepatol. 2013 Jan;12(1):36-43.
Abstract

Hepatitis C virus infection among drug addicts in Italy.
Stroffolini T, D'Egidio PF, Aceti A,  et al
J Med Virol. 2012 Oct;84(10):1608-1612.
Abstract

 

    Conference Reports, Abstracts, and Posters 
 
  Prognostic value of FIB4 in HIV positive patients of the Icona cohort co-infected or not with HCV
C. Mussini, P. Lorenzini, A. De Luca, et al

(XX International AIDS Conference)
Abstract

Montenegro
 

     Journal Papers, Abstracts, and Commentaries
 
  FULL TEXT ARTICLE
Hepatitis C virus genotypes in Serbia and Montenegro: The prevalence and clinical significance.
Svirtlih N, Delic D, Simonovic J, et al
World J Gastroentero
l. 2007 Jan 21;13(3):355-60
Paper

The Netherlands
 

     Journal Papers, Abstracts, and Commentaries
 
  Successful implementation of hepatitis C virus treatment in two large HIV clinics in Amsterdam: hepatitis C virus treatment cascade of care.
Saris J, van den Berk G, Moha DA, et al
AIDS
. 2017 Jul 31;31(12):1779-1780.
Abstract

Acute Hepatitis C in the Netherlands; characteristics of the epidemic in 2014.
Hullegie SJ, van den Berk GE, Leyten EM,  et al
Clin Microbiol Infect
. 2015 Oct 16
Abstract

Changes in HIV RNA and CD4 cell count following acute HCV infection in chronically HIV-infected individuals.
Gras L, de Wolf F, Smit C, Prins M,  et al 
J Acquir Immune Defic Syndr
. 2014 Dec 31
Abstract

Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review.
Lieveld FI, van Vlerken LG, Siersema PD, van Erpecum KJ.
A
nn Hepatol.
2013 May-Jun;12(3):380-91.
Abstract


Norway
 

     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
Meijerink H, White RA, Løvlie A,  
BMC Infect Dis. 2017 Aug 3;17(1):541
Paper

Hepatitis C - a health problem also in Norway.
Vik IS, Skaug K, Dalgard O, et al   
Tidsskr Nor Laegeforen.
2008 Feb 28;128(5):563-566.
Abstract


Poland
 

     Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016.
Rosińska M, Parda N, Kołakowska A,  et al
PLoS
One
. 2017 Sep 20

Paper

The problem of elimination of HCV infections in Poland
Zieliński A, Rosińska M. 
Przegl Eidemiol
. 2017;71(1):3-14.
Abstract

FULL-TEXT ARTICLE
What affects response rates in primary healthcare-based programmes? An analysis of individual and unit-related factors associated with increased odds of non-response based on HCV screening in the general population in Poland.
Parda N, Stępień M, Zakrzewska K,  
BMJ Open. 2016 Dec 7;6(12):e013359
Paper

FULL-TEXT ARTICLE
The prevalence of mixed genotype infections in Polish patients with hepatitis C.
Gowin E, Bereszyńska I, Adamek A,  et al

Int J Infect Dis
. 2015 Dec 14
Paper

Hepatitis C outbreaks in Poland in 2003-2013. Medical procedures as a dominant route of HCV transmission.
Stępień M, Rosińska M.
Przegl Epidemiol. 2015;69(3):465-472
Abstract

Hepatitis C in Poland in 2013.
Parda N, Rosińska M, Stępień M.

Przegl Epidemiol
. 2015;69(2):257-261
Abstract

Forecasting the disease burden of chronic hepatitis C virus in Poland.
Flisiak R, Halota W, Tomasiewicz K,  et al
Eur J Gastroenterol Hepatol. 2015 Jan;27(1):70-6
Abstract

Hepatitis C in Poland in 2011.
Rosińska M, Parda N, Stepień M.
Przegl Epidemiol
. 2013;67(2):247-51,
Abstract

Distribution of HCV genotypes in Poland.
Panasiuk A, Flisiak R, Mozer-Lisewska I,  et al
Przegl Epidemiol
. 2013;67(1):11-6, 99-103
Abstract

Seroprevalence of hepatitis C virus infection among surgical nurses, their patients and blood donation candidates in Poland.
Ganczak M, Korzeń M, Szych Z.
J Hosp Infect. 2012 Oct 27.
Abstract


Portugal
 

     Journal Papers, Abstracts, and Commentaries
 
 
Chronic hepatitis C - Assessment in civil law: A case study.
Santos BM, Sousa P, Mena F, et al 
J Forensic Leg Med
. 2010 Feb;17(2):99-101.
Abstract

Chronic hepatitis C - Assessment in civil law: A case study.
Santos BM, Sousa P, Mena F, et al

J Forensic Leg Med
. 2010 Feb;17(2):99-101.

Abstract


Romania
 

     Journal Papers, Abstracts, and Commentaries

  FULL-TEXT ARTICLE
New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania.
Manuc M, Preda CM, Popescu CP, et al
J Gastrointestin Liver Dis
. 2017 Dec;26(4):381-386
Paper

FULL-TEXT ARTICLE
HCV non-1b genotypes in injecting drug users from Romania.
Ruta S, Sultana C, Oprea C, et al 
J Infect Dev Ctries
. 2016 May 31;10(5):523-7
Paper

The risk for hepatitis C infection in blood donors in Cluj County, Romania.
Hâţu G, Brumboiu MI, Czernichow P, Bocşan IS.
Transfus Clin Biol. 2014 May 2
Abstract


Serbia
 

     Journal Papers, Abstracts, and Commentaries

  FULL TEXT ARTICLE
Hepatitis C virus genotypes in Serbia and Montenegro: The prevalence and clinical significance.
Svirtlih N, Delic D, Simonovic J, et al
World J Gastroentero
l. 2007 Jan 21;13(3):355-60
Paper

Spain
 

     Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study.
Boix R, Cano R, Gallego P, et al
BMC Health Serv Re
s
. 2017 Jul 5;17(1):461.
Paper


Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.
Grandal M, Pernas B, Mariño A, et al
J Med Virol. 2017 Jan 12.
Abstract

Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.
Rivero-Juarez A, Lopez-Cortes LF, Castaño M,  et al
Eur J Clin Microbiol Infect Dis
. 2016 Oct 27.
Abstract

Hepatitis C seroprevalence in an at-risk population in the southwest Madrid region of Spain.
Alonso López S, Agudo Fernández S, García Del Val A,  et al
Gastroenterol Hepatol
. 2016 Jul 11.
Abstract

FULL-TEXT ARTICLE
Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.
Álvaro-Meca A, Jiménez-Sousa MA, Boyer A,
BMC Infect Dis
.
2016 Mar 12;16(1):1
22.
Paper

Personality disorders among Spanish prisoners starting hepatitis C treatment: Prevalence and associated factors.
Marco A, Antón JJ, Saiz de la Hoya P,  et al
Psychiatry Res
. 2015 Nov 10.
Abstract

Antiviral Therapy must be Offered to all Hepatitis C Patients, as Antiretrovirals to all HIV-Positive Individuals.
Barreiro P.
AIDS Rev
. 2015 Jul-Sep;17(3):186-7.
Abstract

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain.
Rivero-Juarez A, Gutierrez-Valencia A, Castaño M, Merino D,  et al
Eur J Clin Microbiol Infect Dis
. 2015 Sep 5.
Abstract

FULL-TEXT ARTICLE
Treatment guidelines for Hepatitis C in Spain.
Crespo-Casal M.
Rev Esp Sanid Penit. 2015 Oct;17(2):37-47
Paper

Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.
García Comas L, Ordobás Gavín M,  et al
J Med Virol. 2015 May 18.
Abstract

Labour productivity losses caused by premature death associated with hepatitis C in Spain.
Oliva-Moreno J, Peña-Longobardo LM, Alonso S, Fernández-Bolaños A,  et al
Eur J Gastroenterol Hepatol. 2015 Mar 31
Abstract

Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection.
Di Lello FA, Mira JA, Neukam K, et al
Arch Virol
. 2014 Aug 27.
Abstract

Prevalence of Hepatitis C Virus Infection in Alcoholic Patients: Cohort Study and Systematic Review.
Novo-Veleiro I, Calle CD, Domínguez-Quibén S,  et al
Alcohol Alcohol
. 2013 May 19.
Abstract

Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain.
Martró E, Valero A, Jordana-Lluch E, et al
Med Virol. 2011 May;83(5):820-6.
Abstract

 

     Conference Reports, Abstracts, and Posters
 
  HIV, hepatitis B and C virus infections in heroin abusers enrolled in the Methadone Maintenance Program in metropolitan Barcelona, Spain 1992-2010
I. Rivas, E. Faure, E. Martínez, et al
(XIX International AIDS Conference)
Abstract

Sweden
 

     Journal Papers, Abstracts, and Commentaries

  Long-term liver-related morbidity and mortality related to chronic hepatitis C virus infection in Swedish patients with inherited bleeding disorders.
Holmström M, Nangarhari A, Öhman J, et al
Haemophilia
. 2016 Oct 5.
Abstract

Switzerland
 

     Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C Virus Awareness Among Men Who Have Sex With Men in Southwest Switzerland.
Clerc O, Darling K, Calmy A, et al  
Sex Transm Dis
. 2016 Jan;43(1):44-48.
Abstract

FULL-TEXT ARTICLE
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.
Müllhaupt B, Bruggmann P, Bihl F, et al
PLoS One. 2015 Jun 24;10(6):e0125214.
Paper

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.
Bruggmann P
J Viral Hepat
. 2012 Dec;19(12):829-35.
Abstract

Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland.
Overbeck K, Dufour JF, Müllhaupt B, et al
Swiss Med Wkly
. 2010 Feb 3

Abstract


Turkey
 

 
        Journal Papers, Abstracts, and Commentaries
 
  Relationship between IL28B gene rs8099917 polymorphism and SVR in Turkish patients with hepatitis C virus genotype 1.
Akkız H, Akgöllü E, Bekar A,  et al
Clin Res Hepatol Gastroenterol
. 2015 Apr 6.
Abstract

Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey.
Altuglu I, Soyler I, Ozacar T, Erensoy S. 
Int J Infect Dis.
2007 Oct 15;
Abstract


United Kingdom
 

     Journal Papers, Abstracts, and Commentaries
 
 
Limited Impact of Awareness-Raising Campaigns on Hepatitis C Testing Practices among General Practitioners.
McLeod A, Cullen BL, Hutchinson SJ, et al
J Viral Hepat. 2017 May 14.
Abstract

FULL-TEXT ARTICLE
Symptomatic Acute Hepatitis C Infection Following a Single Episode of Unprotected Sexual Intercourse.
Butler B, Narayan B, Potts J, Emmanuel J.
Case Rep Infect Dis. 2016;2016:8639098.
Paper

Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection.
Pereira M, Fialho R.

J Behav Med
. 2016 Aug 9
Abstract

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy.
Aspinall EJ, Mitchell W, Schofield J,  et al  
J Viral Hepat
. 2016 Aug 11.
Abstract

FULL-TEXT ARTICLE
Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial.
Roberts K, Macleod J, Metcalfe C, et al
Trials. 2016 Jul 29;17
 

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland - using spontaneous resolvers as the benchmark comparator.
Innes H, Hutchinson SJ, Obel N, et al  
Hepatology
. 2016 Jan 16.
Abstract

Spatiotemporal reconstruction of the introduction of hepatitis C virus into Scotland and its subsequent regional transmission.
McNaughton AL, Cameron ID, Wignall-Fleming EB,  et al
J Virol
. 2015 Aug 26.
Abstract

High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees?
Orkin C, Leach E, Flanagan S, et al
Epidemiol Infect. 2015 Feb 12:1-4
Abstract

Screening for Hepatitis C in injecting and ex-injecting drug users in North East Essex.
Bishton E, Oluboyede F, Grylls E, Woods L, Thomas S.
Public Health. 2014 Nov;128(11):1036-8.
Abstract

Public health boards fail to prioritise hepatitis C.
Kleebauer A.
Nurs Stand
. 2014 May 16;28(37):0.

Abstract

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.
McDonald SA, Hutchinson SJ, Innes HA,  et al
J Viral Hepat
. 2014 May;21(5):366-76.
Abstract

Living with hepatitis C: a phenomenological study
Hill R, Pfeil M, Moore J, Richardson B.
J Clin Nurs. 2014 May 9.
Abstract

Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.
Marufu M, Williams H, Hill SL, et al
J Med Virol. 2012 Nov;84(11):1737-43.
Abstract

Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.
Sutton AJ, McDonald SA, Palmateer N,  et al
 
Epidemiol Infect
. 2012 Mar 30:1-9.
Abstract

Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007.
Brant LJ, Ramsay ME, Tweed E,  et al
J Clin Virol
. 2010 Apr 15
Abstract

Estimating hepatitis C infection acquired in England, 1986-2000.
Balogun MA, Vyse AJ, Hesketh LM, et al
Epidemiol Infect
. 2009 Mar 10:1-6
Abstract


HCV Epidemiology Main Page Main New/Newsworthy  Home Page      

European Seroprevalence/Incidence Studies
National Challenges